Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Olga Martínez-Sáez, Nuria Chic, Tomás Pascual, Barbara Adamo, Maria Vidal, Blanca González-Farré, Esther Sanfeliu, Francesco Schettini, Benedetta Conte, Fara Brasó-Maristany, Adela Rodríguez, Débora Martínez
Read Frequency and spectrum of PIK3CA somatic mutations in breast cancer by Olga Martínez-Sáez, Nuria Chic, Tomás Pascual, Barbara Adamo, Maria Vidal, Blanca González-Farré, Esther Sanfeliu, Francesco Schettini, Benedetta Conte, Fara Brasó-Maristany, Adela Rodríguez, Débora Martínez in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7222307.txt.
Description
Martínez-Sáez and co-authors map how often PIK3CA mutations occur in breast cancer and what forms they take. Their study appeared in Breast Cancer Research. A mutation test and a matching drug, alpelisib, are approved for advanced cases. Clinicians rely on the test to pick patients for the drug. How many mutations the test misses was unknown.
The team pooled data from 6,338 patients across 10 public studies. They charted the full spread of PIK3CA mutations found. Some tumors carried two or more mutations. The approved test detects only a defined set of them. Computer analysis estimated what share of real mutations fall outside that set. The results matter for patients told their tumor is mutation-free. A negative result may sometimes be a test limit, not biology.
Catalog record
| CREATOR | Olga Martínez-Sáez, Nuria Chic, Tomás Pascual, Barbara Adamo, Maria Vidal, Blanca González-Farré, Esther Sanfeliu, Francesco Schettini, Benedetta Conte, Fara Brasó-Maristany, Adela Rodríguez, Débora Martínez |
|---|---|
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |